US$ 27.05
sglt2 inhibitors and glp-1 receptor agonists in Kidney Transplantation: A Systematic Review and Meta-Analysis Frontiers | GLP−1 receptor agonists
Description
The GLP-1 receptor agonist liraglutide (brand name Saxenda) was FDA-approved for chronic weight management in 2014

Lancet Regional Health Southeast Asia , 14, 100210

H., Jin, G

Although bone turnover markers CTX and P1NP declined, differences among groups were not statistically significant

J., Bleich, S
